Back to News
Market Impact: 0.28
BioStem Secures Up To $40 Mln Committed Equity Facility
Source: Nasdaq
Healthcare & BiotechCompany FundamentalsPrivate Markets & Venture
BioStem Technologies entered into a $40 million committed equity facility with Roth Principal Investments, an affiliate of Roth Capital Partners. The financing provides potential capital to support the regenerative-medicine company and its perinatal tissue allograft products, though the article does not specify drawdown timing or use of proceeds.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
mildly positive
Sentiment Score
0.35
More News
- Polymarket fraud concerns mount as company prepares for potential IPO
- California’s billionaire tax will ‘kickstart a movement’ that spreads to more states, the federal government and other countries, Nobel laureates say
- AI safety efforts will require more compute, not less: experts
- Buffett Son Takes Chair as Berkshire Transition Ends
- SpaceX Nasdaq 100 weight to jump to 2.82% in quarterly rebalance -Bloomberg
- What does the EU have that the U.S. does not?